Pro-KidsNCT05858437
Impact of Propionic Acid on Regulatory T Cell Function in Children With CKD
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion date changed from estimate of Sep 2025 to Jul 8, 2026 Show 4 more changesShow less
- Eligibility criteria expanded, about 16 words
- Study completion pushed from Apr 2026 to Mar 2027
- Secondary endpoints: details revised at 2 of 9 entries
- Site details revised
- Notable Primary completion date: Sep 2024 to Sep 2025
- Study completion date: Sep 2024 to Apr 2026
- Minor Secondary endpoints: 6 to 9v4
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Oct 1, 2023 to Jan 15, 2024
- Study sites: 0 to 1
- Primary completion date: Jun 2024 to Sep 2024
- Notable Start date: Jun 2023 to Oct 1, 2023v2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Change in count of regulatory T-cells from baseline to week 4
Timeframe: Baseline visit (week 0) in comparison to week 4
Secondary (8)
Propionic acid serum levels and targeted metabolomics
Immune cell phenotyping of peripheral blood mononuclear cells (PBMC)
T regulatory cell (Treg) suppression assay
Single cell RNA sequencing of immune cells
Intestinal barrier function
Show 3 moreShow less
Taxonomy of the fecal microbiome
Cardiovascular Phenotyping
Cholesterol levels
Arms and interventions
PA InterventionExperimental
The group which receives the PA as a dietary food supplement. A single capsule contains 500mg of sodiumpropionate, which is taken twice daily for 28 days.
Placebo InterventionPlacebo comparator
The control-group receives a placebo instead of propionate. The placebo contains maltodextrin and the same amount of sodium chloride as compared to the PA intervention. The placebo is taken twice per day for 28 days.
Dietary supplements: Sodium propionate
Other: Placebo
Sites
1 site in 1 country
- Department of Pediatric Gastroenterology, Nephrology and Metabolic Diseases, Charité-Universitätsmedizin BerlinBerlin, State of Berlin, Germany